No Data
Truist Financial Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $480
Cantor Fitzgerald Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $485
Dr. Mehmet Oz Wins Senate Confirmation to Lead Medicare and Medicaid Agency
Truist Financial Sticks to Their Buy Rating for Elevance Health (ELV)
Potatoes, Discount Chains and Drugmakers Offer Havens in Stock-market Bloodbath
Returns On Capital At Elevance Health (NYSE:ELV) Have Stalled